CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus | Zendy

Jade Ghosn | Zendy; Tatiana Bayan | Zendy; Karolin Meixenberger | Zendy; Laurent Tran | Zendy; Pierre Frange | Zendy; Antonella d’Arminio Monforte | Zendy; Robert Zangerle | Zendy; Carmen de Mendoza | Zendy; Evguenia Krastinova | Zendy; Kholoud Porter | Zendy; Laurence Meyer | Zendy; MarieLaure Chaix | Zendy; Tony Kelleher | Zendy; David A. Cooper | Zendy; Pat Grey | Zendy; Robert Finlayson | Zendy; Mark Bloch | Zendy; Tim Ramacciotti | Zendy; Linda Gelgor | Zendy; Don Smith | Zendy; M. John Gill | Zendy; Irja Lutsar | Zendy; Geneviève Chêne | Zendy; François Dabis | Zendy; Rodolphe Thiébaut | Zendy; Dominique Costagliola | Zendy; Marguerite Guiguet | Zendy; Philippe Vanhems | Zendy; Faroudy Boufassa | Zendy; Osamah Hamouda | Zendy; Norbert Bannert | Zendy; Barbara Bartmeyer | Zendy; Anastasia Antoniadou | Zendy; Georgios Chrysos | Zendy; Georgios Daikos | Zendy; Giota Touloumi | Zendy; Nikos Pantazis | Zendy; Όλγα Κατσαρού | Zendy; G Rezza | Zendy; Maria Dorrucci | Zendy; Andrea De Luca | Zendy; Maria Prins | Zendy; Ronald B. Geskus | Zendy; Jannie J. van der Helm | Zendy; Hanneke Schuitemaker | Zendy; Mette Sannes | Zendy; Oddbjørn Brubakk | Zendy; AnneMarte Bakken Kran | Zendy; Magdalena Rosińska | Zendy; Roberto Muga | Zendy; Jordi Tor | Zendy; Felipe García | Zendy; Joan A. Caylà | Zendy; Julia del Amo | Zendy; Santiago Moreno | Zendy; Susana Monge | Zendy; Jorge del Romero | Zendy; Santiago PérezHoyos | Zendy; Anders Sönnerborg | Zendy; Heiner C. Bucher | Zendy; Huldrych F. Günthard | Zendy; Alexandra U. Scherrer | Zendy; Ruslan Malyuta | Zendy; Gary Murphy | Zendy; Margaret Johnson | Zendy; Andrew Phillips | Zendy; Abdel Babiker | Zendy; Deenan Pillay | Zendy; Charles Morrison | Zendy; Robert A. Salata | Zendy; Roy D. Mugerwa | Zendy; Tsungai Chipato | Zendy; Matt A. Price | Zendy; Jill Gilmour | Zendy; Anatoli Kamali | Zendy; Etienne Karita | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus

Author(s) -

Jade Ghosn,

Tatiana Bayan,

Karolin Meixenberger,

Laurent Tran,

Pierre Frange,

Antonella d’Arminio Monforte,

Robert Zangerle,

Carmen de Mendoza,

Evguenia Krastinova,

Kholoud Porter,

Laurence Meyer,

MarieLaure Chaix,

Tony Kelleher,

David A. Cooper,

Pat Grey,

Robert Finlayson,

Mark Bloch,

Tim Ramacciotti,

Linda Gelgor,

Don Smith,

M. John Gill,

Irja Lutsar,

Geneviève Chêne,

François Dabis,

Rodolphe Thiébaut,

Dominique Costagliola,

Marguerite Guiguet,

Philippe Vanhems,

Faroudy Boufassa,

Osamah Hamouda,

Norbert Bannert,

Barbara Bartmeyer,

Anastasia Antoniadou,

Georgios Chrysos,

Georgios Daikos,

Giota Touloumi,

Nikos Pantazis,

Όλγα Κατσαρού,

G Rezza,

Maria Dorrucci,

Andrea De Luca,

Maria Prins,

Ronald B. Geskus,

Jannie J. van der Helm,

Hanneke Schuitemaker,

Mette Sannes,

Oddbjørn Brubakk,

AnneMarte Bakken Kran,

Magdalena Rosińska,

Roberto Muga,

Jordi Tor,

Felipe García,

Joan A. Caylà,

Julia del Amo,

Santiago Moreno,

Susana Monge,

Jorge del Romero,

Santiago PérezHoyos,

Anders Sönnerborg,

Heiner C. Bucher,

Huldrych F. Günthard,

Alexandra U. Scherrer,

Ruslan Malyuta,

Gary Murphy,

Margaret Johnson,

Andrew Phillips,

Abdel Babiker,

Deenan Pillay,

Charles Morrison,

Robert A. Salata,

Roy D. Mugerwa,

Tsungai Chipato,

Matt A. Price,

Jill Gilmour,

Anatoli Kamali,

Etienne Karita

Publication year - 2017

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkx247

Subject(s) - seroconversion , virology , human immunodeficiency virus (hiv) , virus , medicine , immunology , biology , microbiology and biotechnology

The natural clinical and immunological courses following HIV seroconversion with CXCR4-tropic or dual-mixed (X4/DM) viruses are controversial. We compared spontaneous immunological outcome in patients harbouring an X4/DM virus at the time of seroconversion with those harbouring a CCR5-tropic (R5) virus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research